AR101

peanut oral immunotherapy · Aimmune Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for AR101, covering 2021-07-13 to 2024-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008) [Phase 3]